|
Canada-0-WindowsMetal Azienda Directories
|
Azienda News:
- Homepage - OrbiMed
From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives
- OrbiMed - Wikipedia
OrbiMed (OrbiMed Advisors) is an American investment firm based in New York City, United States It is focused on making public and private investments in the Healthcare and Biotechnology industries
- OrbiMed - LinkedIn
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty credit funds
- OrbiMed-backed Pinnacle adds $89M for oral peptides
Pinnacle’s CEO, Jonathan Wang, was previously an investor with OrbiMed, and also once served as chief business officer at Zai Lab, according to his official biography
- OrbiMed raises $4. 3bn for latest biotech funds - pharmaphorum
International healthcare investment group OrbiMed has raised around $4 3 billion in committed financing for distribution across three new private funds that will be used to support life sciences
- Orbimed - 2026 Investor Profile, Portfolio, Team Exits - Tracxn
Explore Orbimed's in-depth investor profile, including top investments, acquisitions, portfolio trends, leadership team, co-investors, and news updates
- OrbiMed investment portfolio | PitchBook
Founded in 1989, OrbiMed is a growth equity firm based in New York The firm seeks to invest in companies operating in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors based in Asia, Europe, and North America
- ORBIMED ADVISORS LLC Top 13F Holdings - WhaleWisdom. com
OrbiMed employs investment strategies focused on the global healthcare sector, including pharmaceutical, biotechnology, medical device, and healthcare services companies
- OrbiMed Raises $4. 3 Billion Across Private Investment Funds
OrbiMed focuses on innovative and growth-oriented opportunities across healthcare sub-sectors, including biopharmaceuticals, medical devices, diagnostics and technology-enabled healthcare
- OrbiMed jumps to number one on the top 100 list of biotech venture . . .
OrbiMed leads 2025 top venture investors in life sciences, rising to #1 with $5 9B across more rounds, while RA drops to #2 Total biopharma investment reached $28 6B
|
|